BARGAGNA, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 218
EU - Europa 141
AS - Asia 121
SA - Sud America 20
AF - Africa 14
Totale 514
Nazione #
US - Stati Uniti d'America 212
IT - Italia 82
SG - Singapore 49
CN - Cina 30
HK - Hong Kong 18
BR - Brasile 15
DE - Germania 12
VN - Vietnam 11
FR - Francia 9
CI - Costa d'Avorio 8
NL - Olanda 8
GB - Regno Unito 6
PL - Polonia 6
SE - Svezia 6
CA - Canada 4
FI - Finlandia 4
SN - Senegal 4
AR - Argentina 3
AT - Austria 3
BD - Bangladesh 3
BG - Bulgaria 3
IN - India 2
JP - Giappone 2
KZ - Kazakistan 2
AE - Emirati Arabi Uniti 1
CR - Costa Rica 1
DZ - Algeria 1
IQ - Iraq 1
JM - Giamaica 1
MA - Marocco 1
NO - Norvegia 1
PK - Pakistan 1
PY - Paraguay 1
RU - Federazione Russa 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 514
Città #
Dallas 45
Ashburn 31
Singapore 23
Santa Clara 22
Milan 18
Hong Kong 17
San Jose 12
Venice 12
Shanghai 11
Los Angeles 9
New York 9
Abidjan 8
Pisa 8
Boardman 7
Frankfurt am Main 6
London 6
Chandler 5
Florence 5
Munich 5
North Bergen 5
Rome 5
Warsaw 5
Dakar 4
Fairfield 4
Hanoi 4
Marseille 4
Turku 4
Beijing 3
Ho Chi Minh City 3
Houston 3
Sofia 3
Cascina 2
Da Nang 2
Fairburn 2
Fisciano 2
Genoa 2
Lauterbourg 2
Redondo Beach 2
Seattle 2
Vienna 2
Wilmington 2
Almaty 1
Amsterdam 1
Astana 1
Asunción 1
Atlanta 1
Baghdad 1
Barretos 1
Brooklyn 1
Buffalo 1
Busto Arsizio 1
Calgary 1
Cambridge 1
Carate Brianza 1
Caserta 1
Chengdu 1
Chennai 1
Cleveland 1
Colatina 1
Conquista 1
Curaçá Municipality 1
Denver 1
Dhaka 1
Duisburg 1
Formiga 1
Franklin 1
Fuzhou 1
Guarulhos 1
Hưng Yên 1
Itabaiana 1
Itabuna 1
Kent 1
La Fortuna 1
Lahore 1
Lawrence 1
Leandro N. Alem 1
Lucca 1
Manassas 1
Maracaibo 1
Mariano Moreno 1
Montreal 1
Muriaé 1
Newark 1
Ogden 1
Osaka 1
Oujda 1
Paris 1
Petrópolis 1
Philadelphia 1
Poplar 1
Porto Alegre 1
Princeton 1
Quanzhou 1
Queens 1
Salvador 1
San Giuliano Terme 1
San Miguel 1
Santos 1
Secaucus 1
Stockholm 1
Totale 385
Nome #
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients 155
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib 131
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients 129
Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC 112
Totale 527
Categoria #
all - tutte 1.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213 0 0 0 0 2 5 1 3 0 1 0 1
2022/202345 2 1 2 1 1 6 0 1 26 0 5 0
2023/202450 3 7 9 1 1 8 5 2 0 3 5 6
2024/2025153 3 5 0 8 17 19 16 10 20 21 18 16
2025/2026247 15 33 29 24 30 17 27 11 15 15 18 13
2026/20276 6 0 0 0 0 0 0 0 0 0 0 0
Totale 527